title: A pilot clinical study of short-term isoflavone supplements in breast cancer patients.
authors.affiliation: University of California, Los Angeles, Department of Surgery, Division of Oncology, 90095, USA.
authors.forename: Maryam R
authors.initials: MR
authors.lastname: Sartippour
authors.forename: Jian Yu
authors.initials: JY
authors.lastname: Rao
authors.forename: Sophia
authors.initials: S
authors.lastname: Apple
authors.forename: Debbie
authors.initials: D
authors.lastname: Wu
authors.forename: Susanne
authors.initials: S
authors.lastname: Henning
authors.forename: Hejing
authors.initials: H
authors.lastname: Wang
authors.forename: Robert
authors.initials: R
authors.lastname: Elashoff
authors.forename: Rosalio
authors.initials: R
authors.lastname: Rubio
authors.forename: David
authors.initials: D
authors.lastname: Heber
authors.forename: Mai N
authors.initials: MN
authors.lastname: Brooks
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001707:Biopsy, Needle; D001943:Breast Neoplasms / Q000097:blood / Q000473:pathology / Q000517:prevention & control* / Q000652:urine; D002455:Cell Division / Q000187:drug effects*; D019587:Dietary Supplements; D005260:Female; D006801:Humans; D007529:Isoflavones / Q000627:therapeutic use*; D008875:Middle Aged; D010865:Pilot Projects; D013025:Glycine max / Q000737:chemistry*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D007529:Isoflavones